| Longitudinal Evaluation and Real-world Evidence of NT201 (NCT05222607) | Merz North America, Inc. | 2023-02-10 |
| A Study of ANV419 Alone or in Combination With Approved Treatments in Patients With Multiple Myeloma (OMNIA-2) (NCT05641324) | Anaveon AG | 2023-02-10 |
| Varithena Versus Endothermal Ablation of the Great Saphenous Vein (VERITAS) (NCT05312970) | Boston Scientific Corporation | 2023-02-10 |
| Study of AK119 and AK112 With or Without Chemotherapy for NSCLC Patients (NCT05636267) | Akeso | 2023-02-10 |
| Elobixibat for Chronic Constipation Without Defecation Desire (NCT05703464) | International University of Health and Welfare | 2023-02-09 |
| Pain Reduction and Ovarian Perfusion Following Uterine Fibroid Embolization (NCT06106633) | Massachusetts General Hospital | 2023-02-09 |
| Intermittent Fasting Interventions on Brain Health in Women (NCT05628727) | McMaster University | 2023-02-09 |
| Oral Statins and Protection From Hearing Loss (NCT04826237) | Northwestern University | 2023-02-09 |
| Antitumor Activity of Vactosertib in Combination With Pembrolizumab in Acral and Mucosal Melanoma Patients Progressed From Prior Immune Check Point Inhibitor (NCT05436990) | Yonsei University | 2023-02-09 |
| Clinical Trial to Evaluate the Effect of a Probiotic Mixture in the Treatment of Atopic Dermatitis in Children (NCT05443490) | Bionou Research, S.L. | 2023-02-08 |
| A Study of End of Dose Phenomena in Subcutaneous Natalizumab Treated Multiple Sclerosis (MS) Participants (NCT05701423) | Biogen | 2023-02-08 |
| Immunonutrition for Diabetic Foot Ulcers (NCT05281562) | Prisma Health-Midlands | 2023-02-08 |
| A Dose Escalation/Expansion Study of MDK-703 in Patients With Advanced or Metastatic Solid Tumors (NCT05716295) | Medikine, Inc. | 2023-02-08 |
| [11C]-(R)-Rolipram to Measure cAMP Signaling Before and After Ketamine (NCT05522673) | National Institute of Mental Health (NIMH) | 2023-02-08 |
| Epinephrine in the Pediatric Intensive Care Unit: A Dose-Effect Trial (NCT05327556) | Boston Children's Hospital | 2023-02-08 |
| Clinical Investigation Evaluating Safety and Efficacy of Selective Intra-arterial 166Holmium Radiation Therapy in Combination With Atezolizumab and Bevacizumab for Non Resectable Hepatocellular Carcinoma (NCT05705791) | Gustave Roussy, Cancer Campus, Grand Paris | 2023-02-07 |
| African American Resilient Caregivers (NCT05711979) | Duke University | 2023-02-07 |
| Trial to Evaluate Safety and Efficacy of KPI-012 Ophthalmic Solution in Participants With PCED (NCT05727878) | Combangio, Inc | 2023-02-07 |
| Early Extubation by ECCO2R Compared to IMV in Patients with Severe Acute Exacerbation of COPD (NCT03584295) | Xenios AG | 2023-02-07 |
| Fast Ultra Low Dose CT Interpretation (NCT05748184) | Philips Electronics Nederland B.V. acting through Philips CTO organization | 2023-02-07 |
| Proximal TEmporary oCclusion Using Balloon Guide Catheter for Mechanical Thrombectomy (NCT05592054) | Changhai Hospital | 2023-02-07 |
| A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours (NCT05605522) | 3B Pharmaceuticals GmbH | 2023-02-07 |
| Novel Induction to Buprenorphine/Naloxone (NCT05644587) | Bicycle Health | 2023-02-06 |
| A Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2.0 in Subjects With Recurrent GBM (NCT05370508) | SonALAsense, Inc. | 2023-02-06 |
| CAR T Cells in Mesothelin-Expressing Breast Cancer (NCT05623488) | University of Pennsylvania | 2023-02-06 |
| IIT-2022-Simultaneous Urolift™ and Median Lobe Enucleation (NCT06157164) | University of Kansas Medical Center | 2023-02-06 |
| A Study of MS-553 in Patients With Relapsed or Refractory B-cell Lymphoma (NCT05720052) | MingSight Pharmaceuticals, Inc | 2023-02-06 |
| Efficacy of a Foot Strengthening Protocol on Sport Performance Kinetics (NCT05574322) | Centre Hospitalier Universitaire de Saint Etienne | 2023-02-03 |
| New Strategy for the Detection and Treatment of Helicobacter Pylori Infections in Primary Care Guided by a Non-invasive PCR in Stool (NCT05495854) | Poitiers University Hospital | 2023-02-03 |
| A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF) (NCT05592275) | Eli Lilly and Company | 2023-02-03 |
| Mirdametinib + BGB-3245 in Advanced Solid Tumors (NCT05580770) | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 2023-02-03 |
| Efficacy and Safety of Salvianolic Acid on AIS (NCT04931628) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2023-02-03 |
| [18F]SF12051 for Imaging the 18-kDa Translocator Protein (TSPO) in Brain and Whole Body of Healthy Subjects (NCT05564429) | National Institute of Mental Health (NIMH) | 2023-02-02 |
| A PHASED, PROSPECTIVE, MULTI-CENTER STUDY OF THE ELITA SYSTEM (NCT05713253) | Johnson & Johnson Surgical Vision, Inc. | 2023-02-02 |
| Daily Online Adaptive Short-Course Radiation Therapy and Concurrent Chemotherapy for Muscle-Invasive Bladder Cancer (NCT05700227) | Varian, a Siemens Healthineers Company | 2023-02-02 |
| Effect of Meal Composition and Timing Modification on Glucose Metabolism, Body Temperature and Sleep (NCT05413928) | Stanford University | 2023-02-01 |
| Acute and Chronic Pain After One-stage Hybrid Arrhythmia Ablation Surgery (NCT05211492) | Universitair Ziekenhuis Brussel | 2023-02-01 |
| Neoadjuvant Aliya™ PEF Soft Tissue Ablation With Systemic Therapy in Early-Stage Resectable NSCLC (NCT05583188) | Galvanize Therapeutics, Inc. | 2023-02-01 |
| Cardiovasculorenal Phenotyping in Fabry Disease Through Noninvasive Testing (NCT05699265) | Children's Hospital Medical Center, Cincinnati | 2023-02-01 |
| Phase 3 Safety and Efficacy Study of CTAP101 Extended-release Capsules in Children With Secondary Hyperparathyroidism (NCT05543928) | OPKO Health, Inc. | 2023-01-31 |
| VTX958 Versus Placebo for the Treatment of Active Psoriatic Arthritis (Tranquility-PsA) (NCT05715125) | Ventyx Biosciences, Inc | 2023-01-31 |
| Study to Assess Efficacy and Safety of NS-018 Compared to BAT in Patients With Myelofibrosis (NCT04854096) | NS Pharma, Inc. | 2023-01-31 |
| Multidimensional Integrated Assessment to Test the Efficacy and Response to Ozanimod in Multiple Sclerosis. (NCT05777902) | I.R.C.C.S. Fondazione Santa Lucia | 2023-01-31 |
| Prime-boost Immunotherapeutic Trial in Men With Biochemical Recurrence After Definitive Local Therapy for Prostate Cancer (NCT05617040) | Barinthus Biotherapeutics | 2023-01-30 |
| A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma. (NCT05763121) | Areteia Therapeutics | 2023-01-30 |
| Durvalumab and Tremelimumab With Platinum-based Chemotherapy in Intrahepatic Cholangiocarcinoma (ICC) (NCT04989218) | University of Alabama at Birmingham | 2023-01-30 |
| Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1 (NCT04480554) | University of Pennsylvania | 2023-01-30 |
| Effects of Flourish HEC Vaginal Care System on Birth-Related Pelvic Floor Disorders (NCT05665569) | Vaginal Biome Science | 2023-01-30 |
| A Study to Assess NEU-723 in Healthy Participants (NCT05633745) | Neuron23 Inc. | 2023-01-30 |
| FreeStyle Libre 3 Continuous Glucose Monitoring System (NCT05962710) | Abbott Diabetes Care | 2023-01-27 |
| Electroporation and Immunotherapy in Metastatic Colorectal Cancer (NCT05609656) | Ismail Gögenur | 2023-01-26 |
| Eumycetoma Long-term Post-Treatment Follow-Up Study (NCT06514183) | Drugs for Neglected Diseases | 2023-01-26 |
| Digital Therapeutic for Adolescent Depressive Symptoms in Hematology, Oncology, and Weight Management (NCT05351866) | Limbix Health, Inc. | 2023-01-26 |
| RRx-001 Given With Irinotecan and Temozolomide for Pediatric Patients With Recurrent or Progressive Malignant Solid and Central Nervous System Tumors (NCT04525014) | EpicentRx, Inc. | 2023-01-26 |
| VTX958 for the Treatment of Moderately to Severely Active Crohn's Disease (NCT05688852) | Ventyx Biosciences, Inc | 2023-01-25 |
| A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults (NCT05703607) | Pfizer | 2023-01-25 |
| Immunotherapy With Non-Ablative Radiation in Previously Untreated Patients With Stage IV NSCLC (NCT05691829) | NYU Langone Health | 2023-01-24 |
| A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2 (NCT05514717) | Day One Biopharmaceuticals, Inc. | 2023-01-24 |
| Complex and Simple Appendicitis: REstrictive or Liberal Post-operative Antibiotic eXposure (CASA RELAX) (NCT05838248) | University of Louisville | 2023-01-24 |
| Decreasing Dosing Regimens of Abiraterone 500 mg in Men With Prostate Cancer to Find Lowest Recommended Dose. (NCT05276492) | University of Chicago | 2023-01-24 |
| A Study of CNTY-101 in Participants With CD19-Positive B-Cell Malignancies (NCT05336409) | Century Therapeutics, Inc. | 2023-01-24 |
| Evaluation of the SRI B. Anthracis Lethal Factor Diagnostic System (NCT05672875) | SRI International | 2023-01-23 |
| Study of ExoFlo for the Treatment of Medically Refractory Crohn's Disease (NCT05130983) | Direct Biologics, LLC | 2023-01-23 |
| A Study of Modakafusp Alfa Together With Daratumumab Adults With Relapsed or Refractory Multiple Myeloma (NCT05590377) | Teva Branded Pharmaceutical Products R&D LLC | 2023-01-23 |
| A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1468 in Healthy Adults ≥50 Years of Age (NCT05701800) | ModernaTX, Inc. | 2023-01-23 |
| New IMPLANTARY SURGERY Protocol ASSISTED BY PASSIVE ROBOTIQUE: Pilot Study (NCT05218941) | University Hospital, Toulouse | 2023-01-23 |
| A Study to Investigate the Radiological Onset of Action After Treatment Initiation With Subcutaneous (SC) Natalizumab in Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) (NCT05532163) | Biogen | 2023-01-23 |
| Expressive Writing in GVHD (NCT05694832) | Northwestern University | 2023-01-21 |
| Study of Pregnancy And Neonatal Health (SPAN) (NCT05515744) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2023-01-20 |
| An Open-Label, FIH Study Evaluating the Safety, Tolerability, and Efficacy of VCTX211 Combination Product in Subjects With T1D (NCT05565248) | CRISPR Therapeutics AG | 2023-01-20 |
| Proof of Concept Study Evaluating BP1.3656 in Patients With Fatigue Following Ischemic Stroke (NCT05240560) | Bioprojet | 2023-01-20 |
| Safety and Efficacy of FSD201 for the Treatment of Chronic Pain Associated With Idiopathic MCAS (MCAD) (NCT05652907) | Quantum Biopharma | 2023-01-19 |
| A Study to Evaluate the Effect of the Experimental GLP-1 Drug PF-07081532 on Blood Levels of Common Birth Control Pills, and Drugs Omeprazole and Midazolam, and Effect of GLP-1 Drug Semaglutide on Midazolam Blood Levels in Healthy Adults With Weight in the Obesity Range (NCT05671653) | Pfizer | 2023-01-19 |
| Study of M5049 in DM and PM Participants (NEPTUNIA) (NCT05650567) | EMD Serono Research & Development Institute, Inc. | 2023-01-19 |
| "Answers in Hours" A Randomized Controlled Trial Using Microbiome Metagenomics for Bile Duct Cultures (NCT05523154) | Mayo Clinic | 2023-01-19 |
| Patient Satisfaction and Visual Outcomes After Bilateral PanOptix Implantation in Patients With Previous Multifocal Contact Lens (NCT05518227) | Vivid Laser Center | 2023-01-19 |
| Exercise and Nutrition Interventions for Platinum Chemotherapy-induced Neuropathy R21 (NCT05452902) | University of Maryland, Baltimore | 2023-01-19 |
| Implementation Study of the ICOPE Program for the Detection of Frailty in the Elderly Within the Territorial Health Professional Communities (CPTS) of Brest Region (NCT05541731) | University Hospital, Brest | 2023-01-19 |
| A Phase II Study of Nivolumab + Ipilimumab in Advanced HCC Patients Who Have Progressed on First Line Atezolizumab + Bevacizumab (NCT05199285) | Academic and Community Cancer Research United | 2023-01-19 |
| Testing Obeticholic Acid for Familial Adenomatous Polyposis (NCT05223036) | National Cancer Institute (NCI) | 2023-01-19 |
| iCP-NI - Safety, Tolerability, Pharmacokinetic, and Immunogenicity Study in Healthy Male and Female Subjects (NCT05740280) | Cellivery Therapeutics, Inc. | 2023-01-19 |
| Long-term Safety of BCX9930 in Participants With Paroxysmal Nocturnal Hemoglobinuria (NCT05741346) | BioCryst Pharmaceuticals | 2023-01-18 |
| 18F-DCFPyL PET/CT in Hepatocellular Carcinoma (NCT05009979) | National Cancer Institute (NCI) | 2023-01-18 |
| Prednisolone Versus Colchicine for Acute Gout in Primary Care (NCT05698680) | University Medicine Greifswald | 2023-01-18 |
| A Study of Avelumab in Real-World Treatment for Patients With Advanced or Metastatic Urothelial Cancer (NCT05568407) | Pfizer | 2023-01-18 |
| A Study to Evaluate How Ontamalimab Works and Assess Its Safety and Tolerability in People With Nonalcoholic Steatohepatitis With Fibrosis Stages 1 to 4 (NCT07052682) | Takeda | 2023-01-18 |
| Resistell Phenotech AST to Determine the Antibiotic Susceptibility of Gram-negative Bacteria Causing Bacteremia (NCT05613322) | Resistell AG | 2023-01-18 |
| A Study to Learn About the Study Medicine Etrasimod in Adults With Moderate to Severe Atopic Dermatitis (AD) Who Have Already Tried Treatments Taken by Mouth or by Injection (NCT05732454) | Pfizer | 2023-01-18 |
| A Study to Evaluate the Efficacy, Safety, and Tolerability of MYK-224 in Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy (NCT05556343) | Bristol-Myers Squibb | 2023-01-18 |
| Effect of Intermittent Oro-esophageal Tube vs Nasogastric Tube in Tracheostomized Patients With Intracerebral Hemorrhage (NCT06203561) | Zeng Changhao | 2023-01-17 |
| A Study to Learn More About Treatment With Damoctocog Alfa Pegol, How it is Used in Every Day Practice ("Real-World"), and How Satisfied People Who Receive Damoctocog Alfa Pegol Are in United States (US) Hemophilia Treatment Centers (NCT05395858) | Bayer | 2023-01-17 |
| A Study of TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid Tumors (NCT05576077) | Turnstone Biologics, Corp. | 2023-01-17 |
| Ultrasound-based Imaging to Detect Early Changes of Hard and Soft Tissue Around Immediately Placed Implants With or Without Soft Tissue Augmentation (NCT05330702) | University of Iowa | 2023-01-17 |
| To Evaluate the Safety, Tolerance and Pharmacokinetics of BAT8007 for Injection in Patients With Advanced Solid Tumors (NCT05879627) | Bio-Thera Solutions | 2023-01-17 |
| Efficacy of Lactobacillus Paracasei PS23 for Patients With Post-COVID-19 Syndrome (NCT05813899) | Mackay Memorial Hospital | 2023-01-16 |
| Mechanical Intervention on the Scalp Microbiome: Setting the Stage for the Future Management of Cicatricial Alopecias (NCT06357169) | University of Minnesota | 2023-01-13 |
| PI3K Delta Inhibitor in Relapsed / Refractory Autoimmune Hemolytic Anemia Patients After Receiving Two or More Lines of Therapy (NCT05676697) | Institute of Hematology & Blood Diseases Hospital, China | 2023-01-13 |
| PMCF Study to Evaluate the VERTICALE® Cervical System in Spine Surgery According to Its Intended Use. (NCT05489822) | Silony Medical GmbH | 2023-01-13 |
| Satisfaction of Patients With Amyotrophic Lateral Sclerosis Regarding Home Assisted Teleconsultation (NCT05621213) | AGIR à Dom | 2023-01-13 |
| Outpatient Antibiotics Following Previable Rupture of Membranes (pPPROM) Between 18 0/7 and 22 6/7 Weeks Gestational Age (NCT05345457) | University Hospitals Cleveland Medical Center | 2023-01-13 |